Advances in stromal cell therapy for management of Alzheimer’s disease
Deposition of misfolded proteins and synaptic failure affects the brain in Alzheimer’s disease (AD). Its progression results in amnesia and cognitive impairment. Absence of treatment is due to excessive loss of neurons in the patients and the delayed effects of drugs. The enhanced pluripotency, prol...
Main Authors: | Rashi Srivastava, Aidong Li, Tirtharaj Datta, Niraj Kumar Jha, Salehikram Talukder, Saurabh Kumar Jha, Zhe-Sheng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.955401/full |
Similar Items
-
An update on stem cell and stem cell-derived extracellular vesicle-based therapy in the management of Alzheimer’s disease
by: Madhan Jeyaraman, et al.
Published: (2023-07-01) -
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects
by: Pingal Pritam, et al.
Published: (2022-01-01) -
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
by: Feng Ye, et al.
Published: (2023-07-01) -
Implications of Microorganisms in Alzheimer’s Disease
by: Pardeep Yadav, et al.
Published: (2022-09-01) -
Impact of the Process Variables on the Yield of Mesenchymal Stromal Cells from Bone Marrow Aspirate Concentrate
by: Madhan Jeyaraman, et al.
Published: (2022-01-01)